Skip to main content
Curtis Pettaway, MD, Urology, Houston, TX, University of Texas M.D. Anderson Cancer Center

CurtisA.PettawayMD

Urology Houston, TX

Professor of Urology, University Tex Houston

Dr. Pettaway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pettaway's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Urology, 1991 - 1993
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Urology, 1987 - 1991
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Surgery, 1986 - 1987
  • University of Texas Southwestern Medical Center/Parkland Memorial Hospital
    University of Texas Southwestern Medical Center/Parkland Memorial HospitalInternship, Transitional Year, 1983 - 1984
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 1984 - 2024
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Top Doctors:SE Texas Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • 7 Things to Know About Penile Cancer
    7 Things to Know About Penile CancerJuly 20th, 2020
  • MDACC 2018: Debate: Organ Preservation in Penile Cancer
    MDACC 2018: Debate: Organ Preservation in Penile CancerNovember 10th, 2018
  • Synthetic Lethality Between Androgen Receptor Signalling and the PARP Pathway in Prostate Cancer
    Synthetic Lethality Between Androgen Receptor Signalling and the PARP Pathway in Prostate CancerAugust 29th, 2017
  • Join now to see all

Hospital Affiliations